This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2021 Remove Drug Development Remove Interoperability Related Topics
Pain management healthcare technology Medical Technology Remote care Leadership Life Science Digital Health Telehealth Telemedicine Mental health More Related Topics >
article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

FEBRUARY 18, 2024

Market Dynamics: Lower valuations: Compared to the heady days of 2021, HealthTech valuations have cooled down, making "soft landing" deals more attractive for both acquirers and targets. Pharmaceutical and Life Sciences Companies: These companies are looking for HealthTech solutions to: Enhance clinical trials and drug development processes.

Pharmaceuticals 61
Pharmaceuticals healthcare technology Digital Health Remote care 61
article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

FEBRUARY 22, 2024

Accessibility and affordability: Addressing cost barriers and developing affordable pain management solutions for diverse populations. Integration and interoperability: Ensuring smooth integration of new technologies with existing healthcare systems for seamless patient care. In 2021, only 1.3% billion for oncology.

Pain management 55
Pain management Mental health Telehealth healthcare technology 55
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 82,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
LinkedIn
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024